TJToufic R. Jildeh

Toufic R. Jildeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Toufic R. Jildeh has a total of 155 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perioperative Management of the Orthopedic Patient Taking Antipsychotics: A Narrative Review

    by Dustin J Kress, Ayush Ippalapelli, Moaid Shaik, Natalie Dunn, Jenna R Skiff, Lucy Nordberg, Toufic R Jildeh

    Purpose: Antipsychotic prescribing continues to rise among older adults, the group most likely to present for orthopedic surgery, and orthopedic surgeons now operate regularly on patients taking these agents. Guidance for managing them around an operation sits largely in the psychiatric, anesthesiology and pharmacologic literature rather than the surgical one. This narrative review gathers the orthopedic-specific evidence and organizes it by whether a finding reflects the medication or the psychiatric illness for which it was prescribed. Findings: Antipsychotic exposure is associated with higher all-cause revision and periprosthetic fracture after total knee arthroplasty, and second-generation exposure raises all-cause and aseptic revision after shoulder arthroplasty independent of psychiatric diagnosis. Venous thromboembolism roughly doubles after primary total knee arthroplasty. Among geriatric hip fracture patients antipsychotics are the only medication class independently linked to in-hospital falls, and preoperative use independently predicts postoperative delirium that prophylaxis does not prevent. Spine, sports medicine and trauma surgery all show worse outcomes in patients carrying a psychiatric diagnosis, yet none of those literatures disentangles the drug from the disorder. Thromboembolism and the shoulder revision signal are the clearest drug-attributable exceptions. Hyperprolactinemia-mediated hypogonadism, metabolic derangement and impaired fracture healing remain plausible but unproven. Nearly all available evidence is retrospective. Conclusion: Antipsychotic therapy should continue through the perioperative period unless a specific reason exists to stop it. Abrupt discontinuation risks psychiatric relapse, which is harder to manage than the perioperative risks the drugs themselves carry. Low bone mineral density, poor glycemic control and thromboembolic risk are all worth addressing before surgery, drawing on psychiatry and internal medicine. Antipsychotics are not recommended for delirium prophylaxis. Whether altering therapy improves orthopedic outcomes has not been studied prospectively.

  • Open Access

    Arthrogenic Muscle Inhibition of the Knee: A Surgeon-Focused Narrative Review of Diagnosis and Management

    by David L Nolan, Humza Bhatti, Nicholas Operti, Doyle Ford, Dustin J Kress, Toufic R Jildeh

    Arthrogenic muscle inhibition (AMI) is a reflexive suppression of quadriceps motor drive that arises from abnormal joint afferent signaling rather than structural failure. It is a common and underrecognized barrier to recovery after knee injury and surgery, reported in more than half of acute anterior cruciate ligament (ACL) injuries and in roughly one-third of patients early after total knee arthroplasty. Even when a reconstruction, repair, or arthroplasty is technically successful, persistent inhibition can limit voluntary quadriceps activation, terminal knee extension, gait, and functional strength. This narrative review synthesizes the current evidence with a surgeon-facing perspective, organized around three areas: the neurophysiology of AMI, its clinical assessment and diagnosis, and current management strategies. The pathophysiology is time-dependent: acute AMI is predominantly a spinal reflex phenomenon driven by effusion, pain, inflammation, and altered mechanoreceptor input, whereas chronic AMI reflects corticospinal and cortical reorganization that responds less reliably to joint-directed treatment alone. AMI has no diagnostic gold standard and is recognized clinically after structural causes are excluded, with the Sonnery-Cottet (SANTI) classification providing a practical bedside grade and quantitative measures such as the central activation ratio reserved for research settings. Among management options, neuromuscular electrical stimulation carries the strongest evidence, supported by meta-analyses of randomized trials after ACL reconstruction, with earlier initiation associated with greater quadriceps strength recovery. Targeted activation exercises and cryotherapy are widely used and supported by observational and experimental work, though the evidence behind them is less direct. We consolidate this evidence into graded summary tables and a proposed bedside clinical pathway. Early recognition of AMI, particularly in high-risk perioperative windows, allows the surgeon to distinguish neuromuscular inhibition from mechanical block, guide patient-specific counseling, and coordinate treatment before recovery is compromised.

  • Open Access

    Pes Anserine Bursitis: An Underrecognized Cause of Medial Knee Pain – A Review of Diagnosis, Associated Conditions, and Evidence-Based Management

    by Brian Tani, Adam Haddad, Griffin Gleeson, Angel Ga Prempeh, Dustin J Kress, Toufic R Jildeh

    Pes anserine bursitis (PAB) is a frequently underrecognized and misdiagnosed cause of medial knee pain. It occurs when there is inflammation of the bursa interposed between the conjoined pes anserine tendons and the underlying proximal tibia. The purpose of this review is to describe the current knowledge regarding the diagnosis and management of PAB by providing an evidence-based overview of clinical exams and treatment modalities. PAB is prevalent across several high-risk populations, including knee osteoarthritis (OA), obesity, type 2 diabetes mellitus, and athletes engaged in repetitive knee flexion activities. Diagnosis is currently limited by the absence of a validated quantitative clinical assessment tool. The main goal of treatment is to reduce associated bursal inflammation and address the underlying biomechanical and systemic contributing factors. The standard of care is conservative intervention, comprising rest, ice, and short-term NSAID use, then physical therapy and, where symptoms persist, intrabursal corticosteroid injection, with response commonly assessed at eight weeks. Surgery is considered only after these measures have been exhausted. Due to the complexity of overlapping medial knee pathology and the absence of a gold-standard diagnostic method, PAB remains a clinical diagnosis that requires thoughtful history-taking, physical examination, and selective use of imaging. This review summarizes essential clinical examination techniques and treatment options for PAB, emphasizing practical recommendations for orthopedic surgeons. The intended audience also includes sports medicine physicians, rehabilitation specialists, and primary care providers, as most cases are managed conservatively. Referral to orthopedic surgery is appropriate only when symptoms persist despite comprehensive conservative therapy. Although PAB is often diagnosed clinically, structural bursitis is confirmed in only a minority of cases, so management relies primarily on clinical assessment rather than imaging findings.

  • Open Access

    Editorial Commentary : Contact Is Not Containment: In High‐Grade Trochlear Dysplasia, the Patellotrochlear Index Quantifies Cartilage Overlap in the Absence of Osseous Constraint

    by Dustin J. Kress, Toufic R. Jildeh

    Patella alta remains among the most critical anatomical risk factors for recurrent patellofemoral instability and failure of patellar stabilization surgery. The Caton‐Deschamps index references the patella to the tibia by measuring the position of the patella relative to the anterosuperior margin of the tibial plateau. In contrast, the patellotrochlear index references the patella to the femoral trochlea by quantifying the proportion of patellar articular cartilage that shows sagittal overlap with trochlear cartilage on magnetic resonance imaging. Under normal trochlear morphology, these measurements closely covary, but they diverge in the presence of abnormal morphology. In high‐grade trochlear dysplasia, the proximal trochlea is elongated, flattened, and often convex beneath a supratrochlear spur. The patella overlaps an expanded cartilage surface that provides minimal osseous constraint. Contact does not equate to containment. Therefore, a reference‐range patellotrochlear index alone is insufficient to exclude a dysplastic knee from consideration for distalizing tibial tubercle osteotomy. Neither index correlates with the instability resolution angle obtained during examination under anesthesia, indicating that static imaging parameters do not fully capture dynamic patellofemoral containment. We must stop letting single 2‐dimensional cutoffs dictate complex, 3‐dimensional surgical decisions.

  • Open Access

    Editorial Commentary : May the Force Be With You—Preoperative Strength Is the Rotator Cuff Retear Predictor We Can Actually Train

    by Dustin J. Kress, Toufic R. Jildeh

    Predicting the clinical course of rotator cuff repairs is one of the most significant and unresolved challenges in shoulder surgery. Most established predictors of retear (e.g., advanced age, fatty infiltration, large tear size, and tendon retraction) are nonmodifiable—already set prior to the time the patient arrives in the operating room. Preoperative shoulder strength, measured as a side‐to‐side deficit on handheld dynamometry, warrants a larger role in discussions of rotator cuff repair outcomes. It is a practical metric (inexpensive, fast, and clinically accessible), and importantly, there is suggestion that shoulder strength may stand as a modifiable predictor of retear. When it comes to predicting rotator cuff healing, may the Force be with you.

  • Fracture Management and Care in Pregnancy

    by Kiran Sharma, Zina Smadi, Mohammad Munir Zaitoun, Fahad Nadeem, Abdullah Ghali, Toufic R. Jildeh

    » Pregnancy alters calcium balance, hormone regulation, and mechanical loading, which together lowers bone mineral density and increases risk of fractures. » Trauma during pregnancy carries significant maternal and fetal risk as low-mechanism injuries can trigger placental abruption, preterm labor, and fetal loss. » Imaging, anesthesia, and surgery require coordinated teams to provide care safely and optimize maternal and fetal outcomes. » Providers must verify pregnancy safety stratifications before medication selection.

  • Metabolic Functions of the Subacromial Bursa

    by Humza Bhatti, Nicholas D. Operti, Toufic R. Jildeh

    » Historically viewed as a passive structure in shoulder pain, the subacromial bursa (SAB) is now understood to have metabolic function and to be an active participant in shoulder health by influencing cytokine production and cellular signaling pathways. » The variability in the SAB anatomically, along with its varied cell types, makes it an important consideration for shoulder health. Synoviocytes, mesenchymal stem cells, fibroblasts, and immune cells from the SAB can largely influence shoulder pathology. » The SAB influences metabolic function through the release of bioactive molecules such as interleukin-1, interleukin-6, tumor necrosis factor-ɑ, transformation growth factor, and basic fibroblast growth factor. These molecules alter shoulder health by modulating the immune/inflammatory response and promoting angiogenesis, cell proliferation, and fibrosis. » The SAB and its metabolic function are indicated in several clinical conditions, such as subacromial impingement syndrome, shoulder osteoarthritis, subacromial bursitis, and rotator cuff tears, demonstrating its importance and clinical utility. » Further understanding of the SAB and its metabolic function as opposed to its anatomical function allows for novel targets and therapeutics in shoulder pathologies that integrate the field of orthopaedics and immunology. Further studies demonstrating the role of the bioactive molecules released by the SAB and its effect on surrounding tissues are paramount for breakthroughs in shoulder health. » In this study, we present a narrative review of the current understanding of the metabolic function of the SAB.


  • Assessment and Management of the Painful Reverse Total Shoulder Arthroplasty

    by Omar Abdalla, Jon Novosel, Chloe Tucker, Toufic R. Jildeh

    » Reverse total shoulder arthroplasty (rTSA) has become the standard surgical treatment for rotator cuff arthropathy, offering reliable improvements in function and pain relief. However, postoperative shoulder pain remains a complex and clinically significant challenge. » The differential diagnosis of a painful rTSA includes infectious, mechanical, and neurological or immunological complications. Key etiologies include periprosthetic joint infection (0.5%-6.7% incidence, 13.8% of all complications), instability, aseptic loosening (glenoid loosening 2.3%, humeral loosening 1.4%), polyethylene wear, scapular notching (reported as high as 96%), postoperative fractures, neurologic injury (up to 3.6%), and metal hypersensitivity (prevalence of 10%-15% in the general population). » Diagnostic workup requires a structured approach combining clinical examination, radiographic analysis, serologic markers, advanced imaging, and intraoperative assessment when necessary. Several etiologies, particularly infection, metal allergy, and polyethylene wear, may present with overlapping symptoms, necessitating a systematic evaluation. » Management of the painful rTSA is diagnosis-specific and ranges from nonoperative interventions (physical therapy, benign neglect, nonsteroidal anti-inflammatory drugs, corticosteroids, or bracing) to surgical revision procedures such as debridement, component exchange, fracture fixation, or tendon lengthening. » Understanding the biomechanical principles of rTSA design, implant positioning, and soft tissue balance is critical for both prevention and treatment of postoperative pain. While biomechanical innovations have improved joint stability and the efficiency of surrounding soft tissue, the expanding use of rTSA continues to pose challenges for complication rates and long-term outcomes, necessitating clinical vigilance and individualized patient management strategies.